EDENRED (EDEN.PA)       50.78  +1.7 (+3.46%)

50.78  +1.7 (+3.46%)

FR0010908533 - Common Stock


Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to EDEN. EDEN was compared to 32 industry peers in the IT Services industry. EDEN has a medium profitability rating, but doesn't score so well on its financial health evaluation. EDEN shows excellent growth, but is valued quite expensive already.




Profitability

Profitability Rating

6

EDEN has a Profit Margin of 19.53%. This is amongst the best returns in the industry. The industry average is 6.06%. EDEN outperforms 100% of its industry peers.
EDEN has a very good Piotroski-F score of 9.00. This indicates a great health and profitability for EDEN.

EDEN's Return On Assets of 3.33% is worse than the rest of the industry. The industry average Return On Assets is 5.59%.
VS Industry

ROA (3.33%) VS Industry: 23% outperformed.

0.54
11.69

Profit Margin (19.53%) VS Industry: 100% outperformed.

0.55
19.53

Valuation

Valuation Rating

2

The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
With a Price/Earnings Ratio of 38.47, EDEN can be considered very expensive at the moment.
With a Price/Earning Ratio of 38.47, EDEN is valued a higher than the industry average, which is at 20.25. 91% of the companies listed in the same industry are cheaper than EDEN!

The Forward Price/Earnings Ratio of 25.36 indicates a quite expensive current valuation of EDEN.
Compared to an average industry Enterprise Value to EBITDA ratio of 12.11, EDEN is valued more expensive than its industry peers. 83% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (38.47) VS Industry: 9% outperformed.

112.94
5.95

Enterprise Value/ EBITDA (14.99) VS Industry: 17% outperformed.

117.59
4.40

Growth

Growth Rating

7

EDEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.36%, which is quite impressive.
The Earnings Per Share is expected to grow by 14.30% on average over the next 5 years. This is quite good.
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
Looking at the last year, EDEN shows a quite strong growth in Revenue. The Revenue has grown by 17.43% in the last year.

When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
EDEN shows a small growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 9.00% yearly.
The Revenue has been growing slightly by 7.39% on average over the past 5 years.
Based on estimates for the next 5 years, EDEN will show a small growth in Revenue. The Revenue will grow by 9.85% on average per year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS9% 3.61% 23.36% 43.65% 29.71% 23.41% 14.3%
Revenue7.39% 5.69% 17.43% 22.77% 17.24% 14.79% 9.85%

Health

Health Rating

2

The Piotroski-F score of EDEN is 9.00. This is a very strong score and indicates great health and profitability for EDEN.
EDEN has a Current Ratio of 0.97. This is a bad value and indicates that EDEN is not financially healthy enough and could expect problems in meeting its short term obligations.
When comparing the Current Ratio of EDEN to the average industry Current Ratio of 1.27, EDEN is less able to pay its short term obligations than its industry peers.
A Quick Ratio of 0.91 indicates that EDEN may have some problems paying its short term obligations.

When comparing the Quick Ratio of EDEN to the average industry Current Ratio of 1.13, EDEN is less able to pay its short term obligations than its industry peers. 83% of its industry peers have a better Quick Ratio.
Based on the Altman-Z score of 0.72, we must say that EDEN is in the distress zone and has some risk of bankruptcy.
When comparing the Altman-Z score of EDEN to the average industry Altman-Z score of 2.65, EDEN is less financially healthy than its industry peers. 100% of its industry peers have a better Altman-Z score.
VS Industry

Quick Ratio (0.91) VS Industry: 17% outperformed.

0.51
6.12

Current Ratio (0.97) VS Industry: 21% outperformed.

0.51
6.12

Altman-Z (0.72) VS Industry: 0% outperformed.

0.72
8.79

Dividend

Dividend Rating

4

The dividend of EDEN is growing, but earnings are growing more, so the dividend growth is sustainable.
EDEN has a Yearly Dividend Yield of 1.80%. Purely for dividend investing, there may be better candidates out there.
EDEN's Dividend Yield is comparable with the industry average which is at 1.80.

The dividend of EDEN has a limited annual growth rate of 1.53%.
EDEN's Dividend Yield is slightly below the S&P500 average, which is at 2.41.
EDEN pays out 72.00% of its income as dividend. This is not a sustainable payout ratio.
VS Industry

Dividend Yield (1.8%) VS Industry: 53% outperformed.

0.83
5.64

EDENRED50.78

EPA:EDEN (2/3/2023, 7:00:00 PM)+1.7 (+3.46%)

Chartmill FA Rating
GICS Sector Information Technology
GICS IndustryGroup Software & Services
GICS Industry IT Services
Earnings (Last) N/A N/A Earnings (Next) N/A N/A
Inst Owners N/A Inst Owner Change N/A
Ins Owners N/A Ins Owner Change N/A
Market Cap 12.62B Analysts 80
Price Target 58.42 (15.05%)

Dividend
Industry RankSector Rank
Dividend Yield 1.8%
Dividend Growth(5Y) 1.53% DP 72%
Div Incr Years 1 Div Non Decr Years 1
Ex-Date N/A

Surprises & Revisions
EPS beat(2) N/A Avg EPS beat(2) -16.34%
Min EPS beat(2) -16.34% Max EPS beat(2) -16.34%
EPS beat(4) N/A Avg EPS beat(4) -12.82%
Min EPS beat(4) -16.34% Max EPS beat(4) -9.3%
Revenue beat(2) 1 Avg Revenue beat(2) 2.27%
Min Revenue beat(2) 2.27% Max Revenue beat(2) 2.27%
Revenue beat(4) 1 Avg Revenue beat(4) 0.79%
Min Revenue beat(4) -0.69% Max Revenue beat(4) 2.27%
PT rev (1m) 0.5% PT rev (3m) 3.5%
EPS NQ rev (1m) N/A EPS NQ rev (3m) N/A
EPS NY rev (1m) 0% EPS NY rev (3m) 3.12%
Revenue NQ rev (1m) N/A Revenue NQ rev (3m) N/A
Revenue NY rev (1m) 0% Revenue NY rev (3m) 2.17%

Valuation
Industry RankSector Rank
PE 38.47
Fwd PE 25.36
P/S 7.04
P/FCF 16.78
P/OCF 14.24
P/B N/A
P/tB N/A
EV/EBITDA 14.99
EPS(TTM) 1.32 EY 2.6%
EPS(NY) 2 Fwd EY 3.94%
FCF(TTM) 3.03 FCFY 5.96%
OCF(TTM) 3.56 OCFY 7.02%
SpS 7.21 BVpS -3.66
TBVpS -13.06 PEG (NY) 0.88
PEG (5Y) 4.27

Profitability
Industry RankSector Rank
ROA 3.33%
ROE N/A
ROIC 13.87%
ROICexc 124.58%
ROICexgc N/A
OM 33.54%
PM 19.53%
GM 90.74%
ROICexgc(3y) N/A ROICexcg growth 3Y N/A
ROICexcg growth 5Y N/A ROICexc(3y) N/A
ROICexc growth 3Y N/A ROICexc growth 5Y N/A
OM growth 3Y -0.39% OM growth 5Y 0.36%
PM growth 3Y 1.44% PM growth 5Y 4.01%
GM growth 3Y 0.61% GM growth 5Y 0.63%
F-Score 9 Asset Turnover 0.17

Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.63
Debt/EBITDA 4.73
Cap/Depr 99.26%
Profit Quality 214.86%
Current Ratio 0.97
Quick Ratio 0.91
Altman-Z 0.72
F-Score 9 WACC 7.97%
ROIC/WACC N/A Cap/Depr(3y) 82.51%
Cap/Depr(5y) 92.86% Profit Quality(3y) 177.39%
Profit Quality(5y) 175.29%

Growth
EPS 1Y 23.36% EPS 3Y 3.61%
EPS 5Y 9% EPS growth Q2Q 25.49%
EPS Next Y 43.65% EPS Next 2Y 29.71%
EPS Next 3Y 23.41% EPS Next 5Y 14.3%
Revenue growth 1Y 17.43% Revenue growth 3Y 5.69%
Revenue growth 5Y 7.39% Revenue growth Q2Q 21.8%
Revenue Next Year 22.77% Revenue Next 2Y 17.24%
Revenue Next 3Y 14.79% Revenue Next 5Y 9.85%
EBIT growth 1Y 21.41% EBIT growth 3Y 5.28%
EBIT growth 5Y 7.77% EBIT Next Year 56.4%
EBIT Next 3Y 25.28% EBIT Next 5Y 15.81%
FCF growth 1Y 48.32% FCF growth 3Y 3.97%
FCF growth 5Y 6.66% OCF growth 1Y 42.67%
OCF growth 3Y 4.72% OCF growth 5Y 7.9%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the EuroNext

Screen Image

Growth Stock Screener

Find more growth stocks the EuroNext

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the EuroNext

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the EuroNext

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the EuroNext